Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.27
+0.13 (1.82%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
59.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Metagenomi Therapeutics | 25.21M |
| MindWalk Holdings | 19.02M |
| Radiopharm Theranostics | 10.86M |
| Plus Therapeutics | 5.26M |
| Alterity Therapeutics | 4.43M |
| Nutriband | 2.28M |
| Rallybio | 674.00K |
| Entera Bio | 124.00K |
EDSA News
- 13 days ago - Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study - GlobeNewsWire
- 24 days ago - Edesa Biotech Reports Fiscal 1st Quarter 2026 Results - GlobeNewsWire
- 3 months ago - Edesa Biotech Reports Fiscal Year 2025 Results - GlobeNewsWire
- 4 months ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 4 months ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 7 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire
- 10 months ago - Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewsWire
- 11 months ago - Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewsWire